...
首页> 外文期刊>British Journal of Cancer >Urinary carcinoembryonic antigen (CEA)-like molecules and urothelial malignancy: a clinical appraisal
【24h】

Urinary carcinoembryonic antigen (CEA)-like molecules and urothelial malignancy: a clinical appraisal

机译:尿癌胚抗原(CEA)样分子与尿路上皮恶性肿瘤的临床评价

获取原文

摘要

A total of 190 patients being treated or followed up for urothelial carcinoma have been studied by the serial estimation of their urinary and plasma CEA levels. Only 46% of patients with a urothelial neoplasm present have a raised urinary CEA level. Infection or ileal conduit urine vitiate the result as they produce high CEA levels in the urine in the absence of any neoplastic disease. The accuracy of urinary CEA estimations is compared with that of cytology. Plasma CEA levels do not serve as a useful guide to the presence of extra-urinary tract tumour spread if taken as isolated readings. However, serial plasma CEA estimations may indicate that metastatic disease is present several months before its detection by the more usual clinical methods in a minority of patients.
机译:通过连续评估其尿液和血浆CEA水平,共研究了190名接受尿路上皮癌治疗或随访的患者。存在尿路上皮肿瘤的患者中只有46%的尿中CEA水平升高。感染或回肠导管尿液可消除这种结果,因为它们在没有任何肿瘤性疾病的情况下会在尿液中产生高CEA水平。比较尿CEA估计的准确性和细胞学的准确性。如果将血浆CEA水平作为孤立的读数,则不能作为尿路外肿瘤扩散的有用指导。但是,串行血浆CEA估计值可能表明,在少数患者中,更常见的临床方法在发现转移性疾病之前已有几个月。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号